tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Cash flow

Compare
488 Followers

Spyre Therapeutics Cash Flow

SYRE's free cash flow for Q3 2025 was $-37.12M. For the 2025 fiscal year, SYRE's free cash flow was decreased by $-57.50M and operating cash flow was $-37.12M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -157.41M$ -99.91M$ -80.14M$ -53.72M$ -75.78M
Investing Cash Flow
$ -353.29M$ -108.39M$ 57.01M$ -22.62M$ -7.60M
Financing Cash Flow
$ 410.91M$ 361.08M$ 42.68M$ 1.39M$ 154.51M
End Cash Position
$ 89.42M$ 189.22M$ 36.42M$ 16.98M$ 91.94M
Free Cash Flow
$ -157.41M$ -99.91M$ -80.18M$ -54.29M$ -80.06M
Currency in USD

Spyre Therapeutics Cash Flow